Literature DB >> 2776831

Indomethacin and acetylsalicylic acid block neurogenic plasma protein extravasation in rat dura mater.

M G Buzzi1, D E Sakas, M A Moskowitz.   

Abstract

Leakage of 125I-bovine serum albumin was measured in rat dura mater, conjunctiva, eyelid and lip, after unilateral electrical stimulation of the trigeminal ganglion. In one animal, 99Tc-human serum albumin leakage was imaged in ipsilateral facial tissues. Pretreatment with indomethacin 1 mg/kg i.p. decreased leakage in dura mater but not in extracranial tissues. When extravasation was expressed as a ratio of stimulated to unstimulated sides, indomethacin 1 mg/kg, or acetylsalicylic acid 50 mg/kg decreased this ratio from 1.80 to 1.27 (P less than 0.01) or from 1.84 to 1.21 (P less than 0.01), respectively. Dexamethasone (1 mg/kg i.p. tid X 1 day) caused only a very small decrease. Only large doses of indomethacin (10 mg/kg) or acetylsalicylic acid (50 mg/kg) reduced substance P (SP)-induced leakage in the dura. The latter results suggest that both drugs block plasma extravasation by acting on neuropeptides-induced changes in vascular permeability and/or smooth muscle contractility. However, inhibition of SP release from sensory axons cannot be excluded at concentrations which block neurogenic plasma extravasation but not SP-induced plasma leakage. Together, these results provide a possible mechanism for the therapeutic effects of indomethacin and acetylsalicylic acid in headache.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2776831     DOI: 10.1016/0014-2999(89)90719-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  27 in total

Review 1.  Migraine and metabolism.

Authors:  G Casucci; V Villani; D Cologno; F D'Onofrio
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

Review 2.  Indomethacin/prochlorperazine/caffeine: a review of its use in the acute treatment of migraine and in the treatment of episodic tension-type headache.

Authors:  Sheridan M Hoy; Lesley J Scott
Journal:  CNS Drugs       Date:  2011-04       Impact factor: 5.749

3.  [Animal models and their results in relation to the therapy of migraine].

Authors:  H Kaube; V Limmroth
Journal:  Schmerz       Date:  1996-06-17       Impact factor: 1.107

Review 4.  A practical guide to the management and prevention of migraine.

Authors:  H C Diener; H Kaube; V Limmroth
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

Review 5.  Mechanism of action of indomethacin in indomethacin-responsive headaches.

Authors:  Oliver Summ; Stefan Evers
Journal:  Curr Pain Headache Rep       Date:  2013-04

6.  GABAA-receptor-mediated effects of progesterone, its ring-A-reduced metabolites and synthetic neuroactive steroids on neurogenic oedema in the rat meninges.

Authors:  V Limmroth; W S Lee; M A Moskowitz
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

Review 7.  Animal migraine models for drug development: status and future perspectives.

Authors:  Inger Jansen-Olesen; Peer Tfelt-Hansen; Jes Olesen
Journal:  CNS Drugs       Date:  2013-12       Impact factor: 5.749

8.  Dural neurogenic inflammation induced by neuropathic pain is specific to cranial region.

Authors:  B Filipović; I Matak; Z Lacković
Journal:  J Neural Transm (Vienna)       Date:  2013-12-24       Impact factor: 3.575

9.  Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater.

Authors:  M G Buzzi; M A Moskowitz; S J Peroutka; B Byun
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

Review 10.  A review of the treatment of primary headaches. Part I: Migraine.

Authors:  M Leone; L Grazzi; D D'Amico; F Moschiano; G Bussone
Journal:  Ital J Neurol Sci       Date:  1995-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.